These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30902655)

  • 21. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
    Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
    Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
    Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex.
    McCord JL; Tsuchimochi H; Kaufman MP
    J Appl Physiol (1985); 2010 Nov; 109(5):1416-23. PubMed ID: 20798273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
    de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous firing and evoked responses of spinal nociceptive neurons are attenuated by blockade of P2X3 and P2X2/3 receptors in inflamed rats.
    Xu J; Chu KL; Brederson JD; Jarvis MF; McGaraughty S
    J Neurosci Res; 2012 Aug; 90(8):1597-606. PubMed ID: 22422599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery and development of gefapixant.
    Ford AP; Dillon MP; Kitt MM; Gever JR
    Auton Neurosci; 2021 Nov; 235():102859. PubMed ID: 34403981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.
    Davenport AJ; Neagoe I; Bräuer N; Koch M; Rotgeri A; Nagel J; Laux-Biehlmann A; Machet F; Coelho AM; Boyce S; Carty N; Gemkow MJ; Hess SD; Zollner TM; Fischer OM
    Sci Rep; 2021 Oct; 11(1):19877. PubMed ID: 34615939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities.
    Flammer LJ; Ellis H; Rivers N; Caronia L; Ghidewon MY; Christensen CM; Jiang P; Breslin PAS; Tordoff MG
    Br J Pharmacol; 2024 Sep; 181(17):3282-3299. PubMed ID: 38745397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Calcium-Dependent Inhibition of ATP-Gated P2X3 Receptors by Bisphosphonate-Induced Endogenous ATP Analog ApppI.
    Ishchenko Y; Shakirzyanova A; Giniatullina R; Skorinkin A; Bart G; Turhanen P; Määttä JA; Mönkkönen J; Giniatullin R
    J Pharmacol Exp Ther; 2017 Jun; 361(3):472-481. PubMed ID: 28404687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulating cough through modulation of sensory nerve function in the airways.
    Spina D; Page CP
    Pulm Pharmacol Ther; 2013 Oct; 26(5):486-90. PubMed ID: 23524012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough.
    Dicpinigaitis PV; McGarvey LP; Canning BJ
    Lung; 2020 Aug; 198(4):609-616. PubMed ID: 32661659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study.
    Morice A; Smith JA; McGarvey L; Birring SS; Parker SM; Turner A; Hummel T; Gashaw I; Fels L; Klein S; Francke K; Friedrich C
    Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 33986030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist.
    Nussbaum JC; Hussain A; Min KC; Marbury TC; Lasseter K; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2022 Nov; 62(11):1435-1444. PubMed ID: 35656754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds.
    Bo X; Alavi A; Xiang Z; Oglesby I; Ford A; Burnstock G
    Neuroreport; 1999 Apr; 10(5):1107-11. PubMed ID: 10321492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.
    Teixeira JM; Bobinski F; Parada CA; Sluka KA; Tambeli CH
    Mol Neurobiol; 2017 Oct; 54(8):6174-6186. PubMed ID: 27709491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P2X purinoceptor-mediated excitation of trigeminal lingual nerve terminals in an in vitro intra-arterially perfused rat tongue preparation.
    Rong W; Burnstock G; Spyer KM
    J Physiol; 2000 May; 524 Pt 3(Pt 3):891-902. PubMed ID: 10790166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised trial of the P2X
    Niimi A; Saito J; Kamei T; Shinkai M; Ishihara H; Machida M; Miyazaki S
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34649978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.
    Hausmann R; Bahrenberg G; Kuhlmann D; Schumacher M; Braam U; Bieler D; Schlusche I; Schmalzing G
    Neuropharmacology; 2014 Apr; 79():603-15. PubMed ID: 24452010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tussive and bronchodilator mechanisms of action for the enaminone E121.
    El-Hashim AZ; Edafiogho IO; Jaffal SM; Yousif MH; Ezeamuzie CI; Kombian SB
    Life Sci; 2011 Sep; 89(11-12):378-87. PubMed ID: 21798272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.